Concepedia

Author

Michelle Martinot‐Peignoux

Inserm

Also Known As

Michelle Martinot‐Peignoux, Michelle Martinot–Peignoux

11

Publications

1.1K

Citations

11

H-Index

21

Concepts

All Affiliations

InsermHôpital BeaujonUniversité Paris CitéDélégation Paris 7Hôpital Bichat-Claude-Bernard
MM

About

Michelle Martinot‐Peignoux is an author at Inserm specializing in hepatitis, hepatitis c, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

442

2

Hepatology

2

2

442

3

Cell Biology

1

1

122

4

Immunology

1

1

122

5

Pathology

1

1

122

Michelle Martinot‐Peignoux

×

8

Publications

977

Citations

8

H-Index

YearCitations

Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

Sarah Maylin, Michelle Martinot‐Peignoux, Rami Moucari,

Gastroenterology

2008

320

Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin†

Michelle Martinot‐Peignoux, Christiane Stern, Sarah Maylin,

Hepatology

2009

174

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C

Ana Carolina Cardoso, Roberto José de Carvalho‐Filho, Christiane Stern,

Liver International

2011

147

Relapse of hepatitis C virus–associated mixed cryoglobulinemia vasculitis in patients with sustained viral response

Dan‐Avi Landau, David Saadoun, Philippe Halfon,

Arthritis & Rheumatism

2008

132

<i>In vivo</i> hepatic endoplasmic reticulum stress in patients with chronic hepatitis C

Tarik Asselah, Ivan Bièche, Abdellah Mansouri,

The Journal of Pathology

2010

122

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody

Sarah Maylin, Michelle Martinot‐Peignoux, Marie–Pierre Ripault,

Liver International

2009

41

Precore/Core promoter variants to predict significant fibrosis in both <scp>HB</scp>eAg positive and negative chronic hepatitis B

Martine Lapalus, Cédric Laouenan, Ana Carolina Cardoso,

Liver International

2015

25

Long‐term outcome of primary non‐responders to tenofovir therapy in <scp>HIV</scp>/<scp>HBV</scp>‐co‐infected patients: impact of <scp>HBV</scp> genotype G

Olivier Lada, Anne Gervais, Michel Branger,

Liver International

2011

16

Page 1